Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335764
Status:
COMPLETED
Last Update Posted:
2018-07-02
First Post:
2006-06-08
Brief Title:
Sorafenib Combined With Erlotinib Tipifarnib or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-08
First Submit QC Date:
June 8 2006
Study First Post Date:
2006-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-31
Last Update Post Date:
2018-07-02
Last Update Post Date Type:
ACTUAL